El Salvador vs Mexico: Cause of death, by non-communicable diseases, female
El Salvador
60.5%
in 2021
Mexico
59.5%
in 2021
El Salvador rank
123rd
Mexico rank
124th
Cause of death, by non-communicable diseases, female over time
- El Salvador
- Mexico
How they compare
El Salvador currently reports 60.5% against 59.5% in Mexico, a difference of 1.0%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Mexico ahead.
El Salvador ranks 123rd and Mexico ranks 124th of 185 countries.
Across the 3 decades both report, El Salvador averaged higher in 1 and Mexico in 2.
Head to head by decade
| Decade | El Salvador | Mexico | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 60.7% | 76.2% | 15.5% | Mexico |
| 2010s | 74.5% | 84.1% | 9.5% | Mexico |
| 2020s | 61.8% | 60.8% | 1.0% | El Salvador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, El Salvador or Mexico?
- El Salvador, at 60.5% against 59.5% in Mexico as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between El Salvador and Mexico?
- 1.0%, with El Salvador ahead.
- How many years of comparable data are there for El Salvador and Mexico?
- 6 years are reported by both, from 2000 to 2021.
- How do El Salvador and Mexico rank globally for cause of death, by non-communicable diseases, female?
- El Salvador ranks 123rd and Mexico ranks 124th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.